Sandimmune Capsule, Liquid Filled
Product Images NDC 0078-0241

6 FDA label images from Novartis Pharmaceuticals Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sandimmune (NDC 0078-0241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Package Label – 50 mg Injection (Sandimmune 01)

Principal Display Panel – Package Label – 50 mg Injection (Sandimmune 01)
Sandimmune Injection 250 mg/5 mL sterile solution for intravenous infusion, made by Novartis Pharmaceuticals Corporation. The packaging carton indicates it contains 10 ampuls. It includes product information such as inactive ingredients, dilution instructions, and storage conditions. Distributed by Novartis Pharmaceuticals Corporation.*
FDA Label Image

Chemical Structure Of Cyclosporine (Sandimmune 02)

Chemical Structure Of Cyclosporine (Sandimmune 02)
Chemical structure of cyclosporine as depicted in the image, showing its molecular formula C62H111N11O12 and molecular weight 1202.63. The structure displays a cyclic peptide arrangement with labeled side groups and amino acid residues.*
FDA Label Image

Sandoz Logo (Sandimmune 03)

Sandoz Logo (Sandimmune 03)
Sandimmune 100 mg capsule, liquid filled, oral dosage form. The packaging is a white bottle with a child-resistant cap, containing 100 capsules. The label shows the product name Sandimmune, the active ingredient cyclosporine at 100 mg strength, and is labeled by Novartis Pharmaceuticals Corporation.*
FDA Label Image

Principal Display Panel 25 mg Soft Gelatin Capsules (Sandimmune 04)

Principal Display Panel 25 mg Soft Gelatin Capsules (Sandimmune 04)
Box packaging label for Sandimmune 25 mg soft gelatin capsules, containing cyclosporine capsules USP. The label shows the product name, strength, dosage form, and manufacturer information from Novartis Pharmaceuticals Corporation. It includes handling instructions and warnings, a UPC barcode, and directions for capsule removal from the blister pack. The label specifies 30 soft gelatin capsules per container.*
FDA Label Image

Principal Display Panel 100 mg Soft Gelatin Capsules (Sandimmune 05)

Principal Display Panel 100 mg Soft Gelatin Capsules (Sandimmune 05)
Sandimmune 100 mg soft gelatin capsules packaging label showing cyclosporine capsules, USP by Novartis Pharmaceuticals Corporation. The label includes dosage form details, warnings about non-interchangeability with Neoral, storage instructions, and manufacturer and distributor information. The product is presented in a carton design with multiple panels displaying the brand name, product strength, and capsule image.*
FDA Label Image

Principal Display Panel – Package Label – 100 mg Oral Solution (Sandimmune 06)

Principal Display Panel – Package Label – 100 mg Oral Solution (Sandimmune 06)
Sandimmune Oral Solution 100 mg/mL (cyclosporine oral solution, USP) in a 50 mL package by Novartis Pharmaceuticals Corporation. The label includes a dosage warning for non-bioequivalence to Neoral, usage instructions for the precision pump, storage instructions, and manufacturer details. The product is for oral use and prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.